$192.00
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through five segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems, BD Interventional, and BD Life Sciences. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery. Its Life Sciences segment includes diagnostic solutions and biosciences.
Country

US

CEO

Mr. Thomas Polen

IPO date

1963

Employees

72,000

ISIN

US0758871091

Website

www.bd.com

Key stats

Open

$189.95

Volume

2.52M

Market cap

$52.30B

Prev. close

$192.00

Impl / hst vl

-

Open interest

$0.00

$186.95

Day’s Range

$192.29

$140.11

52W Range

$213.08

Valuation

38
Valuation score
Overvalued
P/E
53.21
P/S
2.41
P/B
2.05
Current ratio
0.87
Debt / Equity
0.69
ROE
3.80%
Gross margin
46.76%
Income growth
-221.22%
FCF growth
23.04

Sep

30

Dividends

The next payment date will be Sep 30, 2026

Div. per Share

$1.05

Div. Yield

0.55%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Hold

The average rating from top 11 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$189.46
The top 16 analysts forecasts that 12-month price may decrease by 1.32%, with a low of $162.61 and a high of $236.95
$162.61
Low
$189.46
Avg
$236.95
High
Current price

Earnings

Q2 ‘26 revenue
$4.98B
Q2 ‘26 net income
$377.00M
Revenue
Net income
Previous EPS
$2.90
Estimate EPS
$3.17
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply